Currently, some published studies found that urinary NGAL and urinary IL-18 can be used as a biomarker to identify the differentiating ATN from HRS and other causes of AKI in cirrhosis (Morelli et al., 2021). This evidence concerns the gene LCN2 and acute kidney injury.